Home Roche pays $8.3bn for drug's potential
 

Keywords :   


Roche pays $8.3bn for drug's potential

2014-08-26 16:02:00| Biotech - Topix.net

Swiss pharmaceutical company Roche Holding has agreed to buy US biotech company InterMune for $8.3 billion in cash in order to get hold of a promising respiratory drug, in the latest multibillion-dollar deal in a consolidating pharmaceutical and biotechnology sector.

Tags: potential pays drugs roche

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.07Hurricane Beryl Update Statement
01.07Summary for Hurricane Beryl (AT2/AL022024)
01.07BASFs TECH Academy Introduces Louisiana High School Students to Technical Careers
01.07Comericas Patterson Helps Entrepreneurs Grow Their Waste and Recycling Businesses
01.07Hitachi Zosen Inova Acquires Babcock & Wilcox's Denmark-Based Renewable Parts and Services Subsidiary
01.07Hurricane Beryl Graphics
01.07Hurricane Beryl Public Advisory Number 11A
01.07Summary for Hurricane Beryl (AT2/AL022024)
More »